Source Gene Targeted by 315 Gala, Actual Controller is Director of Berry Genomics

MaticHoleFiller · 2026-03-18T07:00:51+00:00

The 315 Evening Gala exposed that Yuanchuang Gene Company engaged in false advertising, exaggerating the beauty and therapeutic effects of its exosome products, reminding consumers to be vigilant against merchants' marketing tactics and infringement of consumer rights.

MaticHoleFiller

2026-03-18 07:00:51

Abstract generation in progress

Special Topic: Improving Consumer Quality — Focus on the 2026 “315 Gala”

Are you harmed by various marketing tricks from merchants? Unable to get complaints about faulty products? The Black Cat Complaint Platform is available 24/7 to help you solve consumer issues. [If you encounter disputes, just go to Black Cat Complaint.]

Source: Caixin

The 315 Gala exposed that some companies in the market are engaging in false advertising. They promote their exosome products as not only capable of beautifying and anti-aging but also exaggerate claims that they can treat various diseases. Among them is a company called Yuan Chuang Genetics. This company is not only a high-tech enterprise and a specialized, innovative enterprise but has also been used as a promotional example by government agencies. According to Qichacha data, the actual controller Zhao Hui is a director of Bairui Genetics (000710.SZ), a listed A-share company.

Sina Statement: This message is reproduced from Sina’s partner media. Sina.com publishes this article to share more information and does not imply endorsement of its views or verification of its content. The article is for reference only and does not constitute investment advice. Investors operate at their own risk.

Massive information, precise analysis, all on Sina Finance APP

Editor: Song Yafang

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.